--- a +++ b/clusters/9knumclustersv2/clust_1033.txt @@ -0,0 +1,30 @@ +Due to unknown effects of this therapy on a fetus, pregnant women are excluded from this research. The male partner should use a condom. Females of child-bearing potential must be willing to utilize one of the more effective birth control methods during the study unless female has had a hysterectomy or tubal ligation +TREATMENT: Pregnant women are excluded from this research; the male partner should use a condom; females of child-bearing potential must be willing to utilize one of the more effective birth control methods during the study unless female has had a hysterectomy or tubal ligation +Sexually active patients must be willing to utilize one of the more effective birth control methods during the study and for months after the study is concluded; the male partner should use a condom +Males who are sexually active and not willing to use a condom, and have a partner who is capable of becoming pregnant, if neither has had surgery to become sterilized, and/or who are not willing to use double barrier or whose partner is not using a highly effective method of birth control +Sexually active patients must be willing to utilize one of the more effective birth control methods for months after the T cell infusion +INCLUSION - TREATMENT: Sexually active patients must be willing to utilize one of the more effective birth control methods during the study and for months after the study is concluded; the male partner should use a condom +INCLUSION - INFUSION: Sexually active patients must be willing to utilize one of the more effective birth control methods during the study and for months after the study is concluded; the male partner should use a condom +TREATMENT INCLUSION: Sexually active patients must be willing to utilize one of the more effective birth control methods during the study and for months after the study is concluded; the male partner should use a condom +Sexually active patients must be willing to utilize one of the more effective birth control methods for months after the T cell infusion; male partner should use a condom +Sexually active patients must be willing to utilize one of the more effective birth control methods for months after the ATL infusion; male partner should use a condom +ELIGIBILITY CRITERIA AT TIME OF TREATMENT: Sexually active patients must be willing to utilize one of the more effective birth control methods during the study and for months after the study is concluded; the male partner should use a condom +Pregnant women are excluded from this research; the male partner should use a condom; females of child-bearing potential must be willing to utilize one of the more effective birth control methods during the study unless female has had a hysterectomy or tubal ligation +Sexually active patients must be willing to utilize one of the more effective birth control methods during the study and for months after the study is concluded; the male partner should use a condom +INCLUSION - TREATMENT: Sexually active patients must be willing to utilize one of the more effective birth control methods for months after the cytotoxic T-lymphocyte (CTL) infusion; male partner should use a condom +Not pregnant or lactating; sexually active patients must be willing to utilize one of the more effective birth control methods during the study and for months after the study is concluded; the male partner should use a condom +ELIGIBILITY CRITERIA- LYMPHODEPLETION/INFUSION OF tvs-CTL: Patients must not be pregnant or lactating; sexually active patients must be willing to utilize one of the more effective birth control methods during the study and for months after the study is concluded; the male partner should use a condom +AT THE TIME OF INFUSION: Sexually active subjects must be willing to utilize one of the more effective birth control methods for months after the T cell infusion; the male partner should use a condom +TREATMENT: Sexually active patients must be willing to utilize one of the more effective birth control methods during the study and for months after the study is concluded; the male partner should use a condom +TREATMENT: Pregnant women are excluded from this research; the male partner should use a condom; females of child-bearing potential must be willing to utilize one of the more effective birth control methods during the study unless female has had a hysterectomy or tubal ligation +Sexually active patients must be willing to utilize one of the more effective birth control methods during the study and for months after the study is concluded; the male partner should use a condom +Sexually active patients must be willing to utilize one of the more effective birth control methods during the study and for months after the study is concluded; the male partner should use a condom +Sexually active patients must be willing to utilize one of the more effective birth control methods during the study and for months after the study is concluded; the male partner should use a condom +Sexually active patients must be willing to utilize one of the more effective birth control methods for months after the cytotoxic T lymphocyte (CTL) infusion; male partner should use a condom +Sexually active patients must be willing to utilize one of the more effective birth control methods for months after the CTL infusion; male partner should use a condom +Sexually active patients must be willing to utilize one of the more effective birth control methods during the study and for months after the study is concluded; the male partner should use a condom +Sexually active patients must be willing to utilize one of the more effective birth control methods during the study and for months after the study is concluded; the male partner should use condom +Sexually active patients must be willing to utilize one of the more effective birth control methods during the study and for months after the study is concluded; the male partner should use a condom +AT THE TIME OF INFUSION: Sexually active patients must be willing to utilize one of the more effective birth control methods during the study and for months after the study is concluded; the male partner should use a condom +Sexually active patients must be willing to utilize one of the more effective birth control methods for months after the CTL infusion; the male partner should use a condom +Patients who are potentially fertile and sexually active must be willing to utilize effective birth control